{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:59:04Z","timestamp":1791968344696,"version":"4.3.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM133732"],"award-info":[{"award-number":["R35GM133732"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R21NS125218-01"],"award-info":[{"award-number":["1R21NS125218-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007445","name":"Matthew Larson Foundation for Pediatric Brain Tumors","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    How abnormal neurodevelopment relates to the tumour aggressiveness of medulloblastoma (MB), the most common type of embryonal tumour, remains elusive. Here we uncover a neurodevelopmental epigenomic programme that is hijacked to induce MB metastatic dissemination. Unsupervised analyses of integrated publicly available datasets with our newly generated data reveal that SMARCD3 (also known as BAF60C) regulates Disabled\u20091 (DAB1)-mediated Reelin signalling in Purkinje cell migration and MB metastasis by orchestrating\n                    <jats:italic>cis<\/jats:italic>\n                    -regulatory elements at the\n                    <jats:italic>DAB1<\/jats:italic>\n                    locus. We further identify that a core set of transcription factors, enhancer of zeste homologue\u20092 (EZH2) and nuclear factor\u2009I\u2009X (NFIX), coordinates with the\n                    <jats:italic>cis<\/jats:italic>\n                    -regulatory elements at the\n                    <jats:italic>SMARCD3<\/jats:italic>\n                    locus to form a chromatin hub to control SMARCD3 expression in the developing cerebellum and in metastatic MB. Increased SMARCD3 expression activates Reelin\u2013DAB1-mediated Src kinase signalling, which results in a MB response to Src inhibition. These data deepen our understanding of how neurodevelopmental programming influences disease progression and provide a potential therapeutic option for patients with MB.\n                  <\/jats:p>","DOI":"10.1038\/s41556-023-01093-0","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T12:02:58Z","timestamp":1677499378000},"page":"493-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["A neurodevelopmental epigenetic programme mediated by SMARCD3\u2013DAB1\u2013Reelin signalling is hijacked to promote medulloblastoma metastasis"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3574-3379","authenticated-orcid":false,"given":"Han","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Poore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evridiki","family":"Asimakidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Razskazovskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Ayrapetian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunjin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Wanggou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4111-1017","authenticated-orcid":false,"given":"Olivier","family":"Saulnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Fellows-Mayle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9080-3277","authenticated-orcid":false,"given":"Guifa","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadanori","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9620-4742","authenticated-orcid":false,"given":"Stephen C.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Raabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1699-8683","authenticated-orcid":false,"given":"Beth E.","family":"Stronach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Agnihotri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Kohanbash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songjian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Herrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy N.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Gittes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Broniscer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongliang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5008-7592","authenticated-orcid":false,"given":"Robert M.","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0503-1183","authenticated-orcid":false,"given":"Sarah J.","family":"Hainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7009-3466","authenticated-orcid":false,"given":"Michael D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2737-6871","authenticated-orcid":false,"given":"Baoli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"1093_CR1","doi-asserted-by":"crossref","unstructured":"Louis, D. N. et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131, 803\u2013820 (2016).","DOI":"10.1007\/s00401-016-1545-1"},{"key":"1093_CR2","doi-asserted-by":"publisher","unstructured":"Zou, H., Poore, B., Broniscer, A., Pollack, I. F. & Hu, B. Molecular heterogeneity and cellular diversity: implications for precision treatment in medulloblastoma. Cancers https:\/\/doi.org\/10.3390\/cancers12030643 (2020).","DOI":"10.3390\/cancers12030643"},{"key":"1093_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","volume":"123","author":"MD Taylor","year":"2012","unstructured":"Taylor, M. D. et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 123, 465\u2013472 (2012).","journal-title":"Acta Neuropathol."},{"key":"1093_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","volume":"31","author":"FMG Cavalli","year":"2017","unstructured":"Cavalli, F. M. G. et al. Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31, 737\u2013754.e6 (2017).","journal-title":"Cancer Cell"},{"key":"1093_CR5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nrc3410","volume":"12","author":"PA Northcott","year":"2012","unstructured":"Northcott, P. A. et al. Medulloblastomics: the end of the beginning. Nat. Rev. Cancer 12, 818\u2013834 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"1093_CR6","unstructured":"Garzia, L. et al. A hematogenous route for medulloblastoma leptomeningeal metastases. Cell 172, 1050 (2018); erratum 173, 1549 (2018)."},{"key":"1093_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S1470-2045(13)70449-2","volume":"14","author":"V Ramaswamy","year":"2013","unstructured":"Ramaswamy, V. et al. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol. 14, 1200\u20131207 (2013).","journal-title":"Lancet Oncol."},{"key":"1093_CR8","doi-asserted-by":"publisher","unstructured":"Fults, D. W., Taylor, M. D. & Garzia, L. Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth. J. Neurosurg. Pediatr. https:\/\/doi.org\/10.3171\/2018.11.PEDS18506 (2019).","DOI":"10.3171\/2018.11.PEDS18506"},{"key":"1093_CR9","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1148\/93.6.1351","volume":"93","author":"CH Chang","year":"1969","unstructured":"Chang, C. H., Housepian, E. M. & Herbert, C. Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93, 1351\u20131359 (1969).","journal-title":"Radiology"},{"key":"1093_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41586-019-1158-7","volume":"572","author":"MC Vladoiu","year":"2019","unstructured":"Vladoiu, M. C. et al. Childhood cerebellar tumours mirror conserved fetal transcriptional programs. Nature 572, 67\u201373 (2019).","journal-title":"Nature"},{"key":"1093_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/wdev.65","volume":"2","author":"JJ White","year":"2013","unstructured":"White, J. J. & Sillitoe, R. V. Development of the cerebellum: from gene expression patterns to circuit maps. Wiley Interdiscip. Rev. Dev. Biol. 2, 149\u2013164 (2013).","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"1093_CR12","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1242\/dev.106559","volume":"141","author":"T Butts","year":"2014","unstructured":"Butts, T., Green, M. J. & Wingate, R. J. Development of the cerebellum: simple steps to make a \u2018little brain\u2019. Development 141, 4031\u20134041 (2014).","journal-title":"Development"},{"key":"1093_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41583-019-0152-2","volume":"20","author":"A Sathyanesan","year":"2019","unstructured":"Sathyanesan, A. et al. Emerging connections between cerebellar development, behaviour and complex brain disorders. Nat. Rev. Neurosci. 20, 298\u2013313 (2019).","journal-title":"Nat. Rev. Neurosci."},{"key":"1093_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12311-017-0899-9","volume":"17","author":"MF Roussel","year":"2018","unstructured":"Roussel, M. F. & Stripay, J. L. Epigenetic drivers in pediatric medulloblastoma. Cerebellum 17, 28\u201336 (2018).","journal-title":"Cerebellum"},{"key":"1093_CR15","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1093\/bioinformatics\/btz066","volume":"35","author":"H Weishaupt","year":"2019","unstructured":"Weishaupt, H. et al. Batch-normalization of cerebellar and medulloblastoma gene expression datasets utilizing empirically defined negative control genes. Bioinformatics 35, 3357\u20133364 (2019).","journal-title":"Bioinformatics"},{"key":"1093_CR16","doi-asserted-by":"crossref","unstructured":"Medvedeva, Y. A. et al. EpiFactors: a comprehensive database of human epigenetic factors and complexes. Database 2015, bav067 (2015).","DOI":"10.1093\/database\/bav067"},{"key":"1093_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","volume":"547","author":"PA Northcott","year":"2017","unstructured":"Northcott, P. A. et al. The whole-genome landscape of medulloblastoma subtypes. Nature 547, 311\u2013317 (2017).","journal-title":"Nature"},{"key":"1093_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41586-019-1434-6","volume":"572","author":"V Hovestadt","year":"2019","unstructured":"Hovestadt, V. et al. Resolving medulloblastoma cellular architecture by single-cell genomics. Nature 572, 74\u201379 (2019).","journal-title":"Nature"},{"key":"1093_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2018.08.004","volume":"34","author":"TC Archer","year":"2018","unstructured":"Archer, T. C. et al. Proteomics, post-translational modifications, and integrative analyses reveal molecular heterogeneity within medulloblastoma subgroups. Cancer Cell 34, 396\u2013410.e8 (2018).","journal-title":"Cancer Cell"},{"key":"1093_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jbiotec.2016.07.028","volume":"236","author":"DP Ivanov","year":"2016","unstructured":"Ivanov, D. P., Coyle, B., Walker, D. A. & Grabowska, A. M. In vitro models of medulloblastoma: choosing the right tool for the job. J. Biotechnol. 236, 10\u201325 (2016).","journal-title":"J. Biotechnol."},{"key":"1093_CR21","doi-asserted-by":"publisher","first-page":"e1002240","DOI":"10.1371\/journal.pcbi.1002240","volume":"7","author":"D Venet","year":"2011","unstructured":"Venet, D., Dumont, J. E. & Detours, V. Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput. Biol. 7, e1002240 (2011).","journal-title":"PLoS Comput. Biol."},{"key":"1093_CR22","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1158\/1078-0432.CCR-15-3011","volume":"22","author":"AR Hanaford","year":"2016","unstructured":"Hanaford, A. R. et al. DiSCoVERing innovative therapies for rare tumors: combining genetically accurate disease models with in silico analysis to identify novel therapeutic targets. Clin. Cancer Res. 22, 3903\u20133914 (2016).","journal-title":"Clin. Cancer Res."},{"key":"1093_CR23","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nrn1113","volume":"4","author":"F Tissir","year":"2003","unstructured":"Tissir, F. & Goffinet, A. M. Reelin and brain development. Nat. Rev. Neurosci. 4, 496\u2013505 (2003).","journal-title":"Nat. Rev. Neurosci."},{"key":"1093_CR24","doi-asserted-by":"crossref","unstructured":"Keshvara, L., Benhayon, D., Magdaleno, S. & Curran, T. Identification of Reelin-induced sites of tyrosyl phosphorylation on Disabled 1. J. Biol. Chem. 276, 16008\u201316014 (2001).","DOI":"10.1074\/jbc.M101422200"},{"key":"1093_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1008-y","volume":"17","author":"A Breschi","year":"2016","unstructured":"Breschi, A. et al. Gene-specific patterns of expression variation across organs and species. Genome Biol. 17, 151 (2016).","journal-title":"Genome Biol."},{"key":"1093_CR26","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1016\/j.cub.2018.07.062","volume":"28","author":"RA Carter","year":"2018","unstructured":"Carter, R. A. et al. A single-cell transcriptional atlas of the developing murine cerebellum. Curr. Biol. 28, 2910\u20132920.e2 (2018).","journal-title":"Curr. Biol."},{"key":"1093_CR27","doi-asserted-by":"publisher","first-page":"11682","DOI":"10.1523\/JNEUROSCI.3656-06.2006","volume":"26","author":"K Leto","year":"2006","unstructured":"Leto, K., Carletti, B., Williams, I. M., Magrassi, L. & Rossi, F. Different types of cerebellar GABAergic interneurons originate from a common pool of multipotent progenitor cells. J. Neurosci. 26, 11682\u201311694 (2006).","journal-title":"J. Neurosci."},{"key":"1093_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/cne.901390407","volume":"139","author":"P Rakic","year":"1970","unstructured":"Rakic, P. & Sidman, R. L. Histogenesis of cortical layers in human cerebellum, particularly the lamina dissecans. J. Comp. Neurol. 139, 473\u2013500 (1970).","journal-title":"J. Comp. Neurol."},{"key":"1093_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8104-5-23","volume":"5","author":"T Miyata","year":"2010","unstructured":"Miyata, T. et al. Migration, early axonogenesis, and Reelin-dependent layer-forming behavior of early\/posterior-born Purkinje cells in the developing mouse lateral cerebellum. Neural Dev. 5, 23 (2010).","journal-title":"Neural Dev."},{"key":"1093_CR30","doi-asserted-by":"crossref","unstructured":"Muller, F. & O\u2019Rahilly, R. The human brain at stages 18\u201320, including the choroid plexuses and the amygdaloid and septal nuclei. Anat. Embryol. 182, 285\u2013306 (1990).","DOI":"10.1007\/BF00185521"},{"key":"1093_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/374719a0","volume":"374","author":"G D\u2019Arcangelo","year":"1995","unstructured":"D\u2019Arcangelo, G. et al. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374, 719\u2013723 (1995).","journal-title":"Nature"},{"key":"1093_CR32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fncel.2018.00484","volume":"12","author":"M Rahimi-Balaei","year":"2018","unstructured":"Rahimi-Balaei, M., Bergen, H., Kong, J. & Marzban, H. Neuronal migration during development of the cerebellum. Front. Cell Neurosci. 12, 484 (2018).","journal-title":"Front. Cell Neurosci."},{"key":"1093_CR33","doi-asserted-by":"publisher","unstructured":"Aldinger, K. A. et al. Spatial and cell type transcriptional landscape of human cerebellar development. Nat Neurosci. https:\/\/doi.org\/10.1038\/s41593-021-00872-y (2021).","DOI":"10.1038\/s41593-021-00872-y"},{"key":"1093_CR34","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213\u20131218 (2013).","journal-title":"Nat. Methods"},{"key":"1093_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17065-z","volume":"11","author":"JV Goodman","year":"2020","unstructured":"Goodman, J. V. et al. The chromatin remodeling enzyme Chd4 regulates genome architecture in the mouse brain. Nat. Commun. 11, 3419 (2020).","journal-title":"Nat. Commun."},{"key":"1093_CR36","doi-asserted-by":"publisher","unstructured":"Skene, P. J. & Henikoff, S. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. eLife https:\/\/doi.org\/10.7554\/eLife.21856 (2017).","DOI":"10.7554\/eLife.21856"},{"key":"1093_CR37","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1002\/cpmb.85","volume":"126","author":"SJ Hainer","year":"2019","unstructured":"Hainer, S. J. & Fazzio, T. G. High-resolution chromatin profiling using CUT&RUN. Curr. Protoc. Mol. Biol. 126, e85 (2019).","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"1093_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/2159-8290.CD-16-0844","volume":"7","author":"G Boulay","year":"2017","unstructured":"Boulay, G. et al. OTX2 activity at distal regulatory elements shapes the chromatin landscape of group 3 medulloblastoma. Cancer Discov. 7, 288\u2013301 (2017).","journal-title":"Cancer Discov."},{"key":"1093_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"ENCODE Project Consortium.","year":"2012","unstructured":"ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"1093_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature16546","volume":"530","author":"CY Lin","year":"2016","unstructured":"Lin, C. Y. et al. Active medulloblastoma enhancers reveal subgroup-specific cellular origins. Nature 530, 57\u201362 (2016).","journal-title":"Nature"},{"key":"1093_CR41","doi-asserted-by":"publisher","unstructured":"Domcke, S. et al. A human cell atlas of fetal chromatin accessibility. Science https:\/\/doi.org\/10.1126\/science.aba7612 (2020).","DOI":"10.1126\/science.aba7612"},{"key":"1093_CR42","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.molcel.2018.06.044","volume":"71","author":"HA Pliner","year":"2018","unstructured":"Pliner, H. A. et al. Cicero predicts cis-regulatory DNA interactions from single-cell chromatin accessibility data. Mol. Cell 71, 858\u2013871.e8 (2018).","journal-title":"Mol. Cell"},{"key":"1093_CR43","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.cell.2018.09.045","volume":"175","author":"SA Lambert","year":"2018","unstructured":"Lambert, S. A. et al. The human transcription factors. Cell 175, 598\u2013599 (2018).","journal-title":"Cell"},{"key":"1093_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0960-9822(02)01403-3","volume":"13","author":"HH Bock","year":"2003","unstructured":"Bock, H. H. & Herz, J. Reelin activates SRC family tyrosine kinases in neurons. Curr. Biol. 13, 18\u201326 (2003).","journal-title":"Curr. Biol."},{"key":"1093_CR45","doi-asserted-by":"publisher","first-page":"8578","DOI":"10.1523\/JNEUROSCI.1656-05.2005","volume":"25","author":"G Kuo","year":"2005","unstructured":"Kuo, G., Arnaud, L., Kronstad-O\u2019Brien, P. & Cooper, J. A. Absence of Fyn and Src causes a reeler-like phenotype. J. Neurosci. 25, 8578\u20138586 (2005).","journal-title":"J. Neurosci."},{"key":"1093_CR46","doi-asserted-by":"publisher","unstructured":"Sun, X. et al. Cardiac-enriched BAF chromatin-remodeling complex subunit Baf60c regulates gene expression programs essential for heart development and function. Biol. Open https:\/\/doi.org\/10.1242\/bio.029512 (2018).","DOI":"10.1242\/bio.029512"},{"key":"1093_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature03071","volume":"432","author":"H Lickert","year":"2004","unstructured":"Lickert, H. et al. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 432, 107\u2013112 (2004).","journal-title":"Nature"},{"key":"1093_CR48","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1128\/MCB.01443-12","volume":"33","author":"NV Jordan","year":"2013","unstructured":"Jordan, N. V. et al. SWI\/SNF chromatin-remodeling factor Smarcd3\/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling. Mol. Cell. Biol. 33, 3011\u20133025 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"1093_CR49","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2016.10.039","volume":"167","author":"B Hu","year":"2016","unstructured":"Hu, B. et al. Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth. Cell 167, 1281\u20131295.e18 (2016).","journal-title":"Cell"},{"key":"1093_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/14734220600804668","volume":"5","author":"M Larouche","year":"2006","unstructured":"Larouche, M. & Hawkes, R. From clusters to stripes: the developmental origins of adult cerebellar compartmentation. Cerebellum 5, 77\u201388 (2006).","journal-title":"Cerebellum"},{"key":"1093_CR51","doi-asserted-by":"publisher","unstructured":"Huq, S. et al. Preclinical efficacy of ribavirin in SHH and group 3 medulloblastoma. J. Neurosurg. Pediatr. https:\/\/doi.org\/10.3171\/2020.8.PEDS20561 (2021).","DOI":"10.3171\/2020.8.PEDS20561"},{"key":"1093_CR52","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41388-019-1036-7","volume":"39","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1\/p53 tumor suppressor pathway. Oncogene 39, 1041\u20131048 (2020).","journal-title":"Oncogene"},{"key":"1093_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/neup.12534","volume":"39","author":"M Natsumeda","year":"2019","unstructured":"Natsumeda, M. et al. Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastoma. Neuropathology 39, 71\u201377 (2019).","journal-title":"Neuropathology"},{"key":"1093_CR54","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/ijc.27455","volume":"131","author":"I Alimova","year":"2012","unstructured":"Alimova, I. et al. Targeting the enhancer of zeste homologue 2 in medulloblastoma. Int. J. Cancer 131, 1800\u20131809 (2012).","journal-title":"Int. J. Cancer"},{"key":"1093_CR55","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1016\/j.celrep.2017.02.073","volume":"18","author":"BT Vo","year":"2017","unstructured":"Vo, B. T. et al. Inactivation of Ezh2 upregulates Gfi1 and drives aggressive Myc-driven group 3 medulloblastoma. Cell Rep. 18, 2907\u20132917 (2017).","journal-title":"Cell Rep."},{"key":"1093_CR56","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1158\/1078-0432.CCR-12-0399","volume":"18","author":"M Smits","year":"2012","unstructured":"Smits, M. et al. EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival. Clin. Cancer Res. 18, 4048\u20134058 (2012).","journal-title":"Clin. Cancer Res."},{"key":"1093_CR57","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1158\/1541-7786.MCR-15-0313","volume":"14","author":"H Xu","year":"2016","unstructured":"Xu, H. et al. Integrative analysis reveals the transcriptional collaboration between EZH2 and E2F1 in the regulation of cancer-related gene expression. Mol. Cancer Res. 14, 163\u2013172 (2016).","journal-title":"Mol. Cancer Res."},{"key":"1093_CR58","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1227604","volume":"338","author":"K Xu","year":"2012","unstructured":"Xu, K. et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science 338, 1465\u20131469 (2012).","journal-title":"Science"},{"key":"1093_CR59","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.molcel.2011.08.011","volume":"43","author":"ST Lee","year":"2011","unstructured":"Lee, S. T. et al. Context-specific regulation of NF-\u03baB target gene expression by EZH2 in breast cancers. Mol. Cell 43, 798\u2013810 (2011).","journal-title":"Mol. Cell"},{"key":"1093_CR60","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00429-018-1801-3","volume":"224","author":"J Fraser","year":"2019","unstructured":"Fraser, J. et al. Granule neuron precursor cell proliferation is regulated by NFIX and intersectin 1 during postnatal cerebellar development. Brain Struct. Funct. 224, 811\u2013827 (2019).","journal-title":"Brain Struct. Funct."},{"key":"1093_CR61","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.2319-13.2014","volume":"34","author":"M Piper","year":"2014","unstructured":"Piper, M. et al. NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development. J. Neurosci. 34, 2921\u20132930 (2014).","journal-title":"J. Neurosci."},{"key":"1093_CR62","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1200\/JCO.2010.30.7231","volume":"29","author":"R Aplenc","year":"2011","unstructured":"Aplenc, R. et al. Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children\u2019s oncology group phase I consortium. J. Clin. Oncol. 29, 839\u2013844 (2011).","journal-title":"J. Clin. Oncol."},{"key":"1093_CR63","doi-asserted-by":"publisher","first-page":"e27035","DOI":"10.1002\/pbc.27035","volume":"65","author":"A Broniscer","year":"2018","unstructured":"Broniscer, A. et al. Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma. Pediatr. Blood Cancer 65, e27035 (2018).","journal-title":"Pediatr. Blood Cancer"},{"key":"1093_CR64","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1002\/cncr.32340","volume":"125","author":"E Galanis","year":"2019","unstructured":"Galanis, E. et al. A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance\/North Central Cancer Treatment Group N0872. Cancer 125, 3790\u20133800 (2019).","journal-title":"Cancer"},{"key":"1093_CR65","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11060-010-0489-x","volume":"104","author":"C Lu-Emerson","year":"2011","unstructured":"Lu-Emerson, C. et al. Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure. J. Neurooncol. 104, 287\u2013291 (2011).","journal-title":"J. Neurooncol."},{"key":"1093_CR66","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11060-012-0848-x","volume":"108","author":"DA Reardon","year":"2012","unstructured":"Reardon, D. A. et al. Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma. J. Neurooncol. 108, 499\u2013506 (2012).","journal-title":"J. Neurooncol."},{"key":"1093_CR67","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1038\/s41596-021-00516-2","volume":"16","author":"BJ Patty","year":"2021","unstructured":"Patty, B. J. & Hainer, S. J. Transcription factor chromatin profiling genome-wide using uliCUT&RUN in single cells and individual blastocysts. Nat. Protoc. 16, 2633\u20132666 (2021).","journal-title":"Nat. Protoc."},{"key":"1093_CR68","doi-asserted-by":"publisher","unstructured":"Chen, A. et al. Chitinase-3-like-1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI147552 (2021).","DOI":"10.1172\/JCI147552"},{"key":"1093_CR69","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman, M. J. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat. Biotechnol. 38, 675\u2013678 (2020).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-023-01093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-023-01093-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-023-01093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T15:51:30Z","timestamp":1679845890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-023-01093-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1038\/s41556-023-01093-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1270726\/v1","asserted-by":"object"}]},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"17 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}